cached image

102 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Inamori K, Willer T, Hara Y, Venzke D, Anderson ME, Clarke NF, Guicheney P, Bönnemann CG, Moore SA, Campbell KP. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. The Journal of Biological Chemistry. 289: 28138-48. PMID 25138275 DOI: 10.1074/jbc.M114.597831  0.68
2014 Brownstein CA, Beggs AH, Homer N, Merriman B, Yu TW, Flannery KC, DeChene ET, Towne MC, Savage SK, Price EN, Holm IA, Luquette LJ, Lyon E, Majzoub J, Neupert P, ... ... Moore SA, et al. An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biology. 15: R53. PMID 24667040 DOI: 10.1186/gb-2014-15-3-r53  0.68
2014 Bönnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Béroud C, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN. Diagnostic approach to the congenital muscular dystrophies. Neuromuscular Disorders : Nmd. 24: 289-311. PMID 24581957 DOI: 10.1016/j.nmd.2013.12.011  0.68
2014 Wallace SE, Conta JH, Winder TL, Willer T, Eskuri JM, Haas R, Patterson K, Campbell KP, Moore SA, Gospe SM. A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations. Neuromuscular Disorders : Nmd. 24: 312-20. PMID 24491487 DOI: 10.1016/j.nmd.2014.01.001  0.68
2014 Crockett CD, Ruggieri A, Gujrati M, Zallek CM, Ramachandran N, Minassian BA, Moore SA. Late adult-onset of X-linked myopathy with excessive autophagy. Muscle & Nerve. 50: 138-44. PMID 24488655 DOI: 10.1002/mus.24197  0.68
2014 Chauveau C, Bonnemann CG, Julien C, Kho AL, Marks H, Talim B, Maury P, Arne-Bes MC, Uro-Coste E, Alexandrovich A, Vihola A, Schafer S, Kaufmann B, Medne L, Hübner N, ... ... Moore SA, et al. Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Human Molecular Genetics. 23: 980-91. PMID 24105469 DOI: 10.1093/hmg/ddt494  0.68
2013 Lin LH, Moore SA, Jones SY, McGlashon J, Talman WT. Astrocytes in the rat nucleus tractus solitarii are critical for cardiovascular reflex control. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18608-17. PMID 24259582 DOI: 10.1523/JNEUROSCI.3257-13.2013  0.68
2013 Nguyen H, Ostendorf AP, Satz JS, Westra S, Ross-Barta SE, Campbell KP, Moore SA. Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins. Acta Neuropathologica Communications. 1: 58. PMID 24252195 DOI: 10.1186/2051-5960-1-58  0.68
2013 Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature. 503: 136-40. PMID 24132234 DOI: 10.1038/nature12605  0.68
2013 Khoo NK, Hebbar S, Zhao W, Moore SA, Domann FE, Robbins ME. Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy. Redox Biology. 1: 70-9. PMID 24024139 DOI: 10.1016/j.redox.2012.12.006  0.68
2013 Yang AC, Ng BG, Moore SA, Rush J, Waechter CJ, Raymond KM, Willer T, Campbell KP, Freeze HH, Mehta L. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy. Molecular Genetics and Metabolism. 110: 345-51. PMID 23856421 DOI: 10.1016/j.ymgme.2013.06.016  0.68
2013 Carss KJ, Stevens E, Foley AR, Cirak S, Riemersma M, Torelli S, Hoischen A, Willer T, van Scherpenzeel M, Moore SA, Messina S, Bertini E, Bönnemann CG, Abdenur JE, Grosmann CM, et al. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. American Journal of Human Genetics. 93: 29-41. PMID 23768512 DOI: 10.1016/j.ajhg.2013.05.009  0.68
2013 Davidson AE, Siddiqui FM, Lopez MA, Lunt P, Carlson HA, Moore BE, Love S, Born DE, Roper H, Majumdar A, Jayadev S, Underhill HR, Smith CO, von der Hagen M, Hubner A, ... ... Moore SA, et al. Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. Brain : a Journal of Neurology. 136: 508-21. PMID 23413262 DOI: 10.1093/brain/aws344  0.68
2013 Cirak S, Foley AR, Herrmann R, Willer T, Yau S, Stevens E, Torelli S, Brodd L, Kamynina A, Vondracek P, Roper H, Longman C, Korinthenberg R, Marrosu G, Nürnberg P, ... ... Moore SA, et al. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Brain : a Journal of Neurology. 136: 269-81. PMID 23288328 DOI: 10.1093/brain/aws312  0.68
2012 Myshrall TD, Moore SA, Ostendorf AP, Satz JS, Kowalczyk T, Nguyen H, Daza RA, Lau C, Campbell KP, Hevner RF. Dystroglycan on radial glia end feet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex. Journal of Neuropathology and Experimental Neurology. 71: 1047-63. PMID 23147502 DOI: 10.1097/NEN.0b013e318274a128  0.68
2012 Joiner ML, Koval OM, Li J, He BJ, Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B, Yang J, Moore SA, Scholz TD, Strack S, Mohler PJ, et al. CaMKII determines mitochondrial stress responses in heart. Nature. 491: 269-73. PMID 23051746 DOI: 10.1038/nature11444  0.68
2012 Willer T, Lee H, Lommel M, Yoshida-Moriguchi T, de Bernabe DB, Venzke D, Cirak S, Schachter H, Vajsar J, Voit T, Muntoni F, Loder AS, Dobyns WB, Winder TL, Strahl S, ... ... Moore SA, et al. ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics. 44: 575-80. PMID 22522420 DOI: 10.1038/ng.2252  0.68
2012 Talman WT, Dragon DN, Jones SY, Moore SA, Lin LH. Sudden death and myocardial lesions after damage to catecholamine neurons of the nucleus tractus solitarii in rat. Cellular and Molecular Neurobiology. 32: 1119-26. PMID 22484855 DOI: 10.1007/s10571-012-9835-1  0.68
2012 Dialynas G, Flannery KM, Zirbel LN, Nagy PL, Mathews KD, Moore SA, Wallrath LL. LMNA variants cause cytoplasmic distribution of nuclear pore proteins in Drosophila and human muscle. Human Molecular Genetics. 21: 1544-56. PMID 22186027 DOI: 10.1093/hmg/ddr592  0.68
2011 Di Blasi C, Bellafiore E, Salih MA, Manzini MC, Moore SA, Seidahmed MZ, Mukhtar MM, Karrar ZA, Walsh CA, Campbell KP, Mantegazza R, Morandi L, Mora M. Variable disease severity in Saudi Arabian and Sudanese families with c.3924 + 2 T > C mutation of LAMA2. Bmc Research Notes. 4: 534. PMID 22166137 DOI: 10.1186/1756-0500-4-534  0.68
2011 Mathews KD, Stephan CM, Laubenthal K, Winder TL, Michele DE, Moore SA, Campbell KP. Myoglobinuria and muscle pain are common in patients with limb-girdle muscular dystrophy 2I. Neurology. 76: 194-5. PMID 21220724 DOI: 10.1212/WNL.0b013e3182061ad4  0.68
2010 Han R, Frett EM, Levy JR, Rader EP, Lueck JD, Bansal D, Moore SA, Ng R, Beltrán-Valero de Bernabé D, Faulkner JA, Campbell KP. Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice. The Journal of Clinical Investigation. 120: 4366-74. PMID 21060153 DOI: 10.1172/JCI42390  0.68
2010 Satz JS, Ostendorf AP, Hou S, Turner A, Kusano H, Lee JC, Turk R, Nguyen H, Ross-Barta SE, Westra S, Hoshi T, Moore SA, Campbell KP. Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 14560-72. PMID 20980614 DOI: 10.1523/JNEUROSCI.3247-10.2010  0.68
2010 Trantow CM, Hedberg-Buenz A, Iwashita S, Moore SA, Anderson MG. Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes. Plos Genetics. 6: e1001008. PMID 20617205 DOI: 10.1371/journal.pgen.1001008  0.68
2009 Satz JS, Philp AR, Nguyen H, Kusano H, Lee J, Turk R, Riker MJ, Hernández J, Weiss RM, Anderson MG, Mullins RF, Moore SA, Stone EM, Campbell KP. Visual impairment in the absence of dystroglycan. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 13136-46. PMID 19846701 DOI: 10.1523/JNEUROSCI.0474-09.2009  0.68
2009 Wakefield SE, Dimberg EL, Moore SA, Tseng BS. Dystrophinopathy presenting with arrhythmia in an asymptomatic 34-year-old man: a case report. Journal of Medical Case Reports. 3: 8625. PMID 19830234 DOI: 10.4076/1752-1947-3-8625  0.68
2009 Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, Muirhead DE, Kunz S, Moore SA, Iannaccone ST, Miyake K, McNeil PL, Mayer U, Oldstone MB, Faulkner JA, et al. Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of alpha-dystroglycan. Proceedings of the National Academy of Sciences of the United States of America. 106: 12573-9. PMID 19633189 DOI: 10.1073/pnas.0906545106  0.68
2009 Rodríguez-Lebrón E, Gouvion CM, Moore SA, Davidson BL, Paulson HL. Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1563-73. PMID 19532137 DOI: 10.1038/mt.2009.123  0.68
2009 Puckett RL, Moore SA, Winder TL, Willer T, Romansky SG, Covault KK, Campbell KP, Abdenur JE. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Neuromuscular Disorders : Nmd. 19: 352-6. PMID 19342235 DOI: 10.1016/j.nmd.2009.03.001  0.68
2009 Chang W, Winder TL, LeDuc CA, Simpson LL, Millar WS, Dungan J, Ginsberg N, Plaga S, Moore SA, Chung WK. Founder Fukutin mutation causes Walker-Warburg syndrome in four Ashkenazi Jewish families. Prenatal Diagnosis. 29: 560-9. PMID 19266496 DOI: 10.1002/pd.2238  0.68
2008 Kobayashi YM, Rader EP, Crawford RW, Iyengar NK, Thedens DR, Faulkner JA, Parikh SV, Weiss RM, Chamberlain JS, Moore SA, Campbell KP. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature. 456: 511-5. PMID 18953332 DOI: 10.1038/nature07414  0.68
2008 Satz JS, Barresi R, Durbeej M, Willer T, Turner A, Moore SA, Campbell KP. Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10567-75. PMID 18923033 DOI: 10.1523/JNEUROSCI.2457-08.2008  0.68
2008 Spuler S, Carl M, Zabojszcza J, Straub V, Bushby K, Moore SA, Bähring S, Wenzel K, Vinkemeier U, Rocken C. Dysferlin-deficient muscular dystrophy features amyloidosis. Annals of Neurology. 63: 323-8. PMID 18306167 DOI: 10.1002/ana.21309  0.68
2008 Kobuke K, Piccolo F, Garringer KW, Moore SA, Sweezer E, Yang B, Campbell KP. A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice. Human Molecular Genetics. 17: 1201-13. PMID 18252746 DOI: 10.1093/hmg/ddn009  0.68
2008 Ferraris S, Clark S, Garelli E, Davidzon G, Moore SA, Kardon RH, Bienstock RJ, Longley MJ, Mancuso M, Gutiérrez Ríos P, Hirano M, Copeland WC, DiMauro S. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Archives of Neurology. 65: 125-31. PMID 18195150 DOI: 10.1001/archneurol.2007.9  0.68
2007 Yokoyama T, Lisi TL, Moore SA, Sluka KA. Muscle fatigue increases the probability of developing hyperalgesia in mice. The Journal of Pain : Official Journal of the American Pain Society. 8: 692-9. PMID 17627895 DOI: 10.1016/j.jpain.2007.05.008  0.68
2006 Moore SA, Shilling CJ, Westra S, Wall C, Wicklund MP, Stolle C, Brown CA, Michele DE, Piccolo F, Winder TL, Stence A, Barresi R, King N, King W, Florence J, et al. Limb-girdle muscular dystrophy in the United States. Journal of Neuropathology and Experimental Neurology. 65: 995-1003. PMID 17021404 DOI: 10.1097/01.jnen.0000235854.77716.6c  0.68
2006 Khalsa SS, Moore SA, Van Hoesen GW. Hughlings Jackson and the role of the entorhinal cortex in temporal lobe epilepsy: from patient A to Doctor Z. Epilepsy & Behavior : E&B. 9: 524-31. PMID 16942917 DOI: 10.1016/j.yebeh.2006.07.017  0.68
2006 Fang X, Faraci FM, Kaduce TL, Harmon S, Modrick ML, Hu S, Moore SA, Falck JR, Weintraub NL, Spector AA. 20-Hydroxyeicosatetraenoic acid is a potent dilator of mouse basilar artery: role of cyclooxygenase. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2301-7. PMID 16782846 DOI: 10.1152/ajpheart.00349.2006  0.48
2005 Occhi S, Zambroni D, Del Carro U, Amadio S, Sirkowski EE, Scherer SS, Campbell KP, Moore SA, Chen ZL, Strickland S, Di Muzio A, Uncini A, Wrabetz L, Feltri ML. Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 9418-27. PMID 16221851 DOI: 10.1523/JNEUROSCI.2068-05.2005  0.68
2005 Collins XH, Harmon SD, Kaduce TL, Berst KB, Fang X, Moore SA, Raju TV, Falck JR, Weintraub NL, Duester G, Plapp BV, Spector AA. Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4. The Journal of Biological Chemistry. 280: 33157-64. PMID 16081420 DOI: 10.1074/jbc.M504055200  0.68
2005 Chen P, Hu S, Yao J, Moore SA, Spector AA, Fang X. Induction of cyclooxygenase-2 by anandamide in cerebral microvascular endothelium. Microvascular Research. 69: 28-35. PMID 15797258 DOI: 10.1016/j.mvr.2005.02.001  0.48
2004 Barresi R, Michele DE, Kanagawa M, Harper HA, Dovico SA, Satz JS, Moore SA, Zhang W, Schachter H, Dumanski JP, Cohn RD, Nishino I, Campbell KP. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nature Medicine. 10: 696-703. PMID 15184894 DOI: 10.1038/nm1059  0.68
2004 Chen P, Hu S, Harmon SD, Moore SA, Spector AA, Fang X. Metabolism of anandamide in cerebral microvascular endothelial cells. Prostaglandins & Other Lipid Mediators. 73: 59-72. PMID 15165032  0.48
2004 Mathews KD, Moore SA. Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces? Archives of Neurology. 61: 27-9. PMID 14732615 DOI: 10.1001/archneur.61.1.27  0.68
2003 Radhakrishnan R, Moore SA, Sluka KA. Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain. 104: 567-77. PMID 12927629 DOI: 10.1016/S0304-3959(03)00114-3  0.68
2003 Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 38: 747-58. PMID 12797959 DOI: 10.1016/S0896-6273(03)00301-5  0.68
2003 Mathews KD, Moore SA. Limb-girdle muscular dystrophy. Current Neurology and Neuroscience Reports. 3: 78-85. PMID 12507416  0.68
2002 Bilunas MH, Moore SA. Cyclooxygenase-2 expression and activity are induced by amyloid-beta 1-42 in brain derived cells. Advances in Experimental Medicine and Biology. 507: 93-9. PMID 12664570  0.68
2002 Girnun GD, Domann FE, Moore SA, Robbins ME. Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Molecular Endocrinology (Baltimore, Md.). 16: 2793-801. PMID 12456800 DOI: 10.1210/me.2002-0020  0.68
2002 Fang X, Chen P, Moore SA. The oxygen radical scavenger pyrrolidine dithiocarbamate enhances interleukin-1beta-induced cyclooxygenase-2 expression in cerebral microvascular smooth muscle cells. Microvascular Research. 64: 405-13. PMID 12453435 DOI: 10.1006/mvre.2002.2431  0.68
2002 Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 110: 639-48. PMID 12230980 DOI: 10.1016/S0092-8674(02)00907-8  0.68
2002 Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature. 418: 417-22. PMID 12140558 DOI: 10.1038/nature00837  0.68
2002 Piccolo F, Moore SA, Mathews KD, Campbell KP. Limb-girdle muscular dystrophies. Advances in Neurology. 88: 273-91. PMID 11908231  0.68
2001 Williard DE, Harmon SD, Preuss MA, Kaduce TL, Moore SA, Spector AA. Production and release of docosahexaenoic acid by differentiated rat brain astrocytes. World Review of Nutrition and Dietetics. 88: 168-72. PMID 11935950 DOI: 10.1159/000059781  0.48
2001 Afifi AK, Follett KA, Greenlee J, Scott WE, Moore SA. Optic neuritis: a novel presentation of Schilder's disease. Journal of Child Neurology. 16: 693-6. PMID 11575614  0.68
2001 Williard DE, Harmon SD, Kaduce TL, Preuss M, Moore SA, Robbins ME, Spector AA. Docosahexaenoic acid synthesis from n-3 polyunsaturated fatty acids in differentiated rat brain astrocytes. Journal of Lipid Research. 42: 1368-76. PMID 11518755  0.48
2001 Watkins PA, Hamilton JA, Leaf A, Spector AA, Moore SA, Anderson RE, Moser HW, Noetzel MJ, Katz R. Brain uptake and utilization of fatty acids: applications to peroxisomal biogenesis diseases. Journal of Molecular Neuroscience : Mn. 16: 87-92; discussion 15. PMID 11478388 DOI: 10.1385/JMN:16:2-3:87  0.68
2001 Katz R, Hamilton JA, Spector AA, Moore SA, Moser HW, Noetzel MJ, Watkins PA. Brain uptake and utilization of fatty acids: recommendations for future research. Journal of Molecular Neuroscience : Mn. 16: 333-5. PMID 11478387 DOI: 10.1385/JMN:16:2-3:333  0.68
2001 Moore SA. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. Journal of Molecular Neuroscience : Mn. 16: 195-200; discussion . PMID 11478374 DOI: 10.1385/JMN:16:2-3:195  0.68
2001 Felice KJ, Moore SA. Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle & Nerve. 24: 352-6. PMID 11353419 DOI: 10.1002/1097-4598(200103)24:3<352::AID-MUS1005>3.0.CO;2-M  0.68
2001 Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle & Nerve. 24: 37-46. PMID 11150964 DOI: 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8  0.68
2000 Piccolo F, Moore SA, Ford GC, Campbell KP. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies. Annals of Neurology. 48: 902-12. PMID 11117547 DOI: 10.1002/1531-8249(200012)48:6<902::AID-ANA11>3.0.CO;2-Z  0.68
2000 Barresi R, Moore SA, Stolle CA, Mendell JR, Campbell KP. Expression of gamma -sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. The Journal of Biological Chemistry. 275: 38554-60. PMID 10993904 DOI: 10.1074/jbc.M007799200  0.68
2000 Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tomé FM, Campbell KP. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Human Molecular Genetics. 9: 2019-27. PMID 10942431  0.68
1999 Girnun GD, Oberley LW, Moore SA, Robbins ME. Eicosapentaenoic acid alters manganese superoxide dismutase immunoreactive protein levels in normal but not malignant central nervous system derived cells. Advances in Experimental Medicine and Biology. 469: 647-53. PMID 10667394  0.68
1999 Grzybicki DM, Moore SA. Implications of prognostic markers in brain tumors. Clinics in Laboratory Medicine. 19: 833-47. PMID 10572718  0.68
1999 Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal D, Hrstka RF, Williamson R, Campbell KP. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell. 98: 465-74. PMID 10481911 DOI: 10.1016/S0092-8674(00)81975-3  0.68
1998 Fang X, Moore SA, Stoll LL, Rich G, Kaduce TL, Weintraub NL, Spector AA. 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin Eproduction in vascular smooth muscle cells. American Journal of Physiology. Heart and Circulatory Physiology. 275: H2113-H2121. PMID 29586789 DOI: 10.1152/ajpheart.1998.275.6.H2113  0.48
1998 Fang X, Moore SA, Stoll LL, Rich G, Kaduce TL, Weintraub NL, Spector AA. 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. The American Journal of Physiology. 275: H2113-21. PMID 9843811  0.48
1998 Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, et al. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. The Journal of Cell Biology. 142: 1461-71. PMID 9744877 DOI: 10.1083/jcb.142.6.1461  0.68
1998 Rich G, Yoder EJ, Moore SA. Regulation of prostaglandin H synthase-2 expression in cerebromicrovascular smooth muscle by serum and epidermal growth factor. Journal of Cellular Physiology. 176: 495-505. PMID 9699502 DOI: 10.1002/(SICI)1097-4652(199809)176:3<495::AID-JCP6>3.0.CO;2-J  0.68
1998 Grzybicki D, Moore SA, Schelper R, Glabinski AR, Ransohoff RM, Murphy S. Expression of monocyte chemoattractant protein (MCP-1) and nitric oxide synthase-2 following cerebral trauma. Acta Neuropathologica. 95: 98-103. PMID 9452827 DOI: 10.1007/s004010050770  0.68
1996 Rich G, Yoder EJ, Prokuski L, Moore SA. Prostaglandin production in cultured cerebral microvascular smooth muscle is serum dependent. The American Journal of Physiology. 270: C1379-87. PMID 8967438  0.68
1995 Moore SA, Hurt E, Yoder E, Sprecher H, Spector AA. Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid. Journal of Lipid Research. 36: 2433-43. PMID 8656081  0.48
1995 Simon JS, Baum JS, Moore SA, Kasson BG. Arginine vasopressin stimulates protein synthesis but not proliferation of cultured vascular endothelial cells. Journal of Cardiovascular Pharmacology. 25: 368-75. PMID 7769800  0.68
1994 Spector AA, Gordon JA, Moore SA. Beta-oxidation of hydroxyeicosatetraenoic acids: a peroxisomal process. World Review of Nutrition and Dietetics. 75: 8-15. PMID 7871836  0.68
1994 Moore SA. Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain: a role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid. World Review of Nutrition and Dietetics. 75: 128-33. PMID 7871814  0.68
1994 Murphy S, Rich G, Orgren KI, Moore SA, Faraci FM. Astrocyte-derived lipoxygenase product evokes endothelium-dependent relaxation of the basilar artery. Journal of Neuroscience Research. 38: 314-8. PMID 7523688 DOI: 10.1002/jnr.490380309  0.68
1993 Davenport RD, Burdick M, Moore SA, Kunkel SL. Cytokine production in IgG-mediated red cell incompatibility. Transfusion. 33: 19-24. PMID 8424264  0.68
1993 Moore SA. Cerebral endothelium and astrocytes cooperate in supplying docosahexaenoic acid to neurons. Advances in Experimental Medicine and Biology. 331: 229-33. PMID 8333338  0.68
1992 Giordano MJ, Mathur SN, Moore SA. Differential metabolism of hydroxyeicosatetraenoic acid isomers by mouse cerebromicrovascular endothelium. Journal of Neurochemistry. 58: 374-82. PMID 1727444  0.68
1992 Haddad SF, Moore SA, Menezes AH, VanGilder JC. Ganglioglioma: 13 years of experience. Neurosurgery. 31: 171-8. PMID 1513423  0.68
1992 Hart MN, Fabry Z, Love-Homan L, Keiner J, Sadewasser KL, Moore SA. Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. The American Journal of Pathology. 141: 421-7. PMID 1497093  0.68
1992 Haddad SF, Moore SA, Schelper RL, Goeken JA. Smooth muscle can comprise the sarcomatous component of gliosarcomas. Journal of Neuropathology and Experimental Neurology. 51: 493-8. PMID 1381414  0.68
1992 Haddad SF, Moore SA, Schelper RL, Goeken JA. Vascular smooth muscle hyperplasia underlies the formation of glomeruloid vascular structures of glioblastoma multiforme. Journal of Neuropathology and Experimental Neurology. 51: 488-92. PMID 1381413  0.68
1992 Tonner D, Belding P, Moore SA, Schlechte JA. Intracranial dissemination of an ACTH secreting pituitary neoplasm--a case report and review of the literature. Journal of Endocrinological Investigation. 15: 387-91. PMID 1324266 DOI: 10.1007/BF03348759  0.68
1992 Xu J, Qu ZX, Moore SA, Hsu CY, Hogan EL. Receptor-linked hydrolysis of phosphoinositides and production of prostacyclin in cerebral endothelial cells. Journal of Neurochemistry. 58: 1930-5. PMID 1313855  0.68
1990 Fabry Z, Waldschmidt MM, Moore SA, Hart MN. Antigen presentation by brain microvessel smooth muscle and endothelium. Journal of Neuroimmunology. 28: 63-71. PMID 2111334 DOI: 10.1016/0165-5728(90)90041-K  0.68
1990 Fabry Z, Waldschmidt MM, Van Dyk L, Moore SA, Hart MN. Activation of CD4+ lymphocytes by syngeneic brain microvascular smooth muscle cells. Journal of Immunology (Baltimore, Md. : 1950). 145: 1099-104. PMID 1974273  0.68
1990 Sahagun G, Moore SA, Hart MN. Permeability of neutral vs. anionic dextrans in cultured brain microvascular endothelium. The American Journal of Physiology. 259: H162-6. PMID 1695819  0.68
1989 Sahagun G, Moore SA, Fabry Z, Schelper RL, Hart MN. Purification of murine endothelial cell cultures by flow cytometry using fluorescein-labeled griffonia simplicifolia agglutinin. The American Journal of Pathology. 134: 1227-32. PMID 2757116  0.68
1989 Moore SA, Figard PH, Spector AA, Hart MN. Brain microvessels produce 12-hydroxyeicosatetraenoic acid. Journal of Neurochemistry. 53: 376-82. PMID 2501450  0.68
1988 Moore SA, Spector AA, Hart MN. Eicosanoid metabolism in cerebromicrovascular endothelium. The American Journal of Physiology. 254: C37-44. PMID 3337219  0.68
1988 Moore SA, Prokuski LJ, Figard PH, Spector AA, Hart MN. Murine cerebral microvascular endothelium incorporate and metabolize 12-hydroxyeicosatetraenoic acid. Journal of Cellular Physiology. 137: 75-85. PMID 3170659 DOI: 10.1002/jcp.1041370109  0.68
1987 Hart MN, Waldschmidt MM, Hanley-Hyde JM, Moore SA, Kemp JD, Schelper RL. Brain microvascular smooth muscle expresses class II antigens. Journal of Immunology (Baltimore, Md. : 1950). 138: 2960-3. PMID 3471815  0.68
1987 Hart MN, VanDyk LF, Moore SA, Shasby DM, Cancilla PA. Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. Journal of Neuropathology and Experimental Neurology. 46: 141-53. PMID 2434625  0.68
1986 Smoker WR, Biller J, Moore SA, Beck DW, Hart MN. Intradural spinal teratoma: case report and review of the literature. Ajnr. American Journal of Neuroradiology. 7: 905-10. PMID 3096113  0.68
1985 Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA. Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. The American Journal of Pathology. 119: 448-55. PMID 4014434  0.68
1984 Moore SA, Strauch AR, Yoder EJ, Rubenstein PA, Hart MN. Cerebral microvascular smooth muscle in tissue culture. In Vitro. 20: 512-20. PMID 6235174 DOI: 10.1007/BF02619625  0.68
1984 Beck DW, Vinters HV, Moore SA, Hart MN, Henn FA, Cancilla PA. Demonstration of adenosine receptors on mouse cerebral smooth muscle membranes. Stroke; a Journal of Cerebral Circulation. 15: 725-7. PMID 6087502  0.68
1983 Beck DW, Vinters HV, Moore SA, Hart MN, Cancilla PA. Uptake of adenosine by cultured cerebral vascular smooth muscle cells. Journal of Neurochemistry. 41: 939-41. PMID 6619860  0.68
Show low-probability matches.